Global Drugs for Osteoarthritis Pain Sales Market Report 2023

Global Drugs for Osteoarthritis Pain Sales Market Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Osteoarthritis Pain Market Size by Type (2018 VS 2022 VS 2029)
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market by Application
1.3.1 Global Drugs for Osteoarthritis Pain Market Share by Application (2018 VS 2022 VS 2029)
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Osteoarthritis Pain Market Perspective (2018-2029)
2.2 Global Drugs for Osteoarthritis Pain Market Size by Region: 2018 VS 2022 VS 2029
2.3 Global Drugs for Osteoarthritis Pain Revenue Market Share by Region (2018-2023)
2.4 Global Drugs for Osteoarthritis Pain Revenue Forecast by Region (2024-2029)
2.5 Geographic Market Analysis: Market Facts & Figures
2.5.1 United States Drugs for Osteoarthritis Pain Estimates and Projections (2018-2029)
2.5.2 Europe Drugs for Osteoarthritis Pain Estimates and Projections (2018-2029)
2.5.3 China Drugs for Osteoarthritis Pain Estimates and Projections (2018-2029)
2.5.4 Japan Drugs for Osteoarthritis Pain Estimates and Projections (2018-2029)
2.5.5 Southeast Asia Drugs for Osteoarthritis Pain Estimates and Projections (2018-2029)
2.5.6 India Drugs for Osteoarthritis Pain Estimates and Projections (2018-2029)
3 Global Drugs for Osteoarthritis Pain Competition Landscape by Players
3.1 Global Top Drugs for Osteoarthritis Pain Players by Revenue (2018-2023)
3.1.1 Global Top Drugs for Osteoarthritis Pain Players by Revenue (2018-2023)
3.1.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Players (2018-2023)
3.2 Global Drugs for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Drugs for Osteoarthritis Pain Revenue
3.4 Global Drugs for Osteoarthritis Pain Market Concentration Ratio
3.4.1 Global Drugs for Osteoarthritis Pain Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Osteoarthritis Pain Revenue in 2022
3.5 Drugs for Osteoarthritis Pain Key Players Head office and Area Served
3.6 Key Players Drugs for Osteoarthritis Pain Product Solution and Service
3.7 Date of Enter into Drugs for Osteoarthritis Pain Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Osteoarthritis Pain Breakdown Data by Type
4.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Type (2018-2023)
4.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2024-2029)
5 Drugs for Osteoarthritis Pain Breakdown Data by Application
5.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Application (2018-2023)
5.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2024-2029)
6 United States Drugs for Osteoarthritis Pain Market Facts & Figures
6.1 United States Drugs for Osteoarthritis Pain Revenue by Company (2018-2023)
6.2 United States Drugs for Osteoarthritis Pain Market Size by Type
6.2.1 United States Drugs for Osteoarthritis Pain Market Size by Type (2018-2023)
6.2.2 United States Drugs for Osteoarthritis Pain Market Size by Type (2024-2029)
6.2.3 United States Drugs for Osteoarthritis Pain Market Share by Type (2018-2029)
6.3 United States Drugs for Osteoarthritis Pain Market Size by Application
6.3.1 United States Drugs for Osteoarthritis Pain Market Size by Application (2018-2023)
6.3.2 United States Drugs for Osteoarthritis Pain Market Size by Application (2024-2029)
6.3.3 United States Drugs for Osteoarthritis Pain Market Share by Application (2018-2029)
7 Europe Drugs for Osteoarthritis Pain Market Facts & Figures
7.1 Europe Drugs for Osteoarthritis Pain Revenue by Company (2018-2023)
7.2 Europe Drugs for Osteoarthritis Pain Market Size by Type
7.2.1 Europe Drugs for Osteoarthritis Pain Market Size by Type (2018-2023)
7.2.2 Europe Drugs for Osteoarthritis Pain Market Size by Type (2024-2029)
7.2.3 Europe Drugs for Osteoarthritis Pain Market Share by Type (2018-2029)
7.3 Europe Drugs for Osteoarthritis Pain Market Size by Application
7.3.1 Europe Drugs for Osteoarthritis Pain Market Size by Application (2018-2023)
7.3.2 Europe Drugs for Osteoarthritis Pain Market Size by Application (2024-2029)
7.3.3 Europe Drugs for Osteoarthritis Pain Market Share by Application (2018-2029)
8 China Drugs for Osteoarthritis Pain Market Facts & Figures
8.1 China Drugs for Osteoarthritis Pain Revenue by Company (2018-2023)
8.2 China Drugs for Osteoarthritis Pain Market Size by Type
8.2.1 China Drugs for Osteoarthritis Pain Market Size by Type (2018-2023)
8.2.2 China Drugs for Osteoarthritis Pain Market Size by Type (2024-2029)
8.2.3 China Drugs for Osteoarthritis Pain Market Share by Type (2018-2029)
8.3 China Drugs for Osteoarthritis Pain Market Size by Application
8.3.1 China Drugs for Osteoarthritis Pain Market Size by Application (2018-2023)
8.3.2 China Drugs for Osteoarthritis Pain Market Size by Application (2024-2029)
8.3.3 China Drugs for Osteoarthritis Pain Market Share by Application (2018-2029)
9 Japan Drugs for Osteoarthritis Pain Market Facts & Figures
9.1 Japan Drugs for Osteoarthritis Pain Revenue by Company (2018-2023)
9.2 Japan Drugs for Osteoarthritis Pain Market Size by Type
9.2.1 Japan Drugs for Osteoarthritis Pain Market Size by Type (2018-2023)
9.2.2 Japan Drugs for Osteoarthritis Pain Market Size by Type (2024-2029)
9.2.3 Japan Drugs for Osteoarthritis Pain Market Share by Type (2018-2029)
9.3 Japan Drugs for Osteoarthritis Pain Market Size by Application
9.3.1 Japan Drugs for Osteoarthritis Pain Market Size by Application (2018-2023)
9.3.2 Japan Drugs for Osteoarthritis Pain Market Size by Application (2024-2029)
9.3.3 Japan Drugs for Osteoarthritis Pain Market Share by Application (2018-2029)
10 Southeast Asia Drugs for Osteoarthritis Pain Market Facts & Figures
10.1 Southeast Asia Drugs for Osteoarthritis Pain Revenue by Company (2018-2023)
10.2 Southeast Asia Drugs for Osteoarthritis Pain Market Size by Type
10.2.1 Southeast Asia Drugs for Osteoarthritis Pain Market Size by Type (2018-2023)
10.2.2 Southeast Asia Drugs for Osteoarthritis Pain Market Size by Type (2024-2029)
10.2.3 Southeast Asia Drugs for Osteoarthritis Pain Market Share by Type (2018-2029)
10.3 Southeast Asia Drugs for Osteoarthritis Pain Market Size by Application
10.3.1 Southeast Asia Drugs for Osteoarthritis Pain Market Size by Application (2018-2023)
10.3.2 Southeast Asia Drugs for Osteoarthritis Pain Market Size by Application (2024-2029)
10.3.3 Southeast Asia Drugs for Osteoarthritis Pain Market Share by Application (2018-2029)
11 India Drugs for Osteoarthritis Pain Market Facts & Figures
11.1 India Drugs for Osteoarthritis Pain Revenue by Company (2018-2023)
11.2 India Drugs for Osteoarthritis Pain Market Size by Type
11.2.1 India Drugs for Osteoarthritis Pain Market Size by Type (2018-2023)
11.2.2 India Drugs for Osteoarthritis Pain Market Size by Type (2024-2029)
11.2.3 India Drugs for Osteoarthritis Pain Market Share by Type (2018-2029)
11.3 India Drugs for Osteoarthritis Pain Market Size by Application
11.3.1 India Drugs for Osteoarthritis Pain Market Size by Application (2018-2023)
11.3.2 India Drugs for Osteoarthritis Pain Market Size by Application (2024-2029)
11.3.3 India Drugs for Osteoarthritis Pain Market Share by Application (2018-2029)
12 Key Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Pfizer Business Overview
12.1.3 Pfizer Drugs for Osteoarthritis Pain Introduction
12.1.4 Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
12.1.5 Pfizer Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Details
12.2.2 Johnson & Johnson Business Overview
12.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Introduction
12.2.4 Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
12.2.5 Johnson & Johnson Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 GlaxoSmithKline Business Overview
12.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Introduction
12.3.4 GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
12.3.5 GlaxoSmithKline Recent Development
12.4 Bayer
12.4.1 Bayer Company Details
12.4.2 Bayer Business Overview
12.4.3 Bayer Drugs for Osteoarthritis Pain Introduction
12.4.4 Bayer Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
12.4.5 Bayer Recent Development
12.5 Eli Lilly
12.5.1 Eli Lilly Company Details
12.5.2 Eli Lilly Business Overview
12.5.3 Eli Lilly Drugs for Osteoarthritis Pain Introduction
12.5.4 Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
12.5.5 Eli Lilly Recent Development
12.6 Novartis
12.6.1 Novartis Company Details
12.6.2 Novartis Business Overview
12.6.3 Novartis Drugs for Osteoarthritis Pain Introduction
12.6.4 Novartis Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
12.6.5 Novartis Recent Development
12.7 Sanofi
12.7.1 Sanofi Company Details
12.7.2 Sanofi Business Overview
12.7.3 Sanofi Drugs for Osteoarthritis Pain Introduction
12.7.4 Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
12.7.5 Sanofi Recent Development
12.8 Horizon Pharma
12.8.1 Horizon Pharma Company Details
12.8.2 Horizon Pharma Business Overview
12.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Introduction
12.8.4 Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
12.8.5 Horizon Pharma Recent Development
12.9 Abbott
12.9.1 Abbott Company Details
12.9.2 Abbott Business Overview
12.9.3 Abbott Drugs for Osteoarthritis Pain Introduction
12.9.4 Abbott Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
12.9.5 Abbott Recent Development
12.10 Mylan
12.10.1 Mylan Company Details
12.10.2 Mylan Business Overview
12.10.3 Mylan Drugs for Osteoarthritis Pain Introduction
12.10.4 Mylan Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
12.10.5 Mylan Recent Development
12.11 Daiichi Sankyo
12.11.1 Daiichi Sankyo Company Details
12.11.2 Daiichi Sankyo Business Overview
12.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Introduction
12.11.4 Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
12.11.5 Daiichi Sankyo Recent Development
12.12 TEVA
12.12.1 TEVA Company Details
12.12.2 TEVA Business Overview
12.12.3 TEVA Drugs for Osteoarthritis Pain Introduction
12.12.4 TEVA Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
12.12.5 TEVA Recent Development
12.13 Almatica Pharma
12.13.1 Almatica Pharma Company Details
12.13.2 Almatica Pharma Business Overview
12.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Introduction
12.13.4 Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
12.13.5 Almatica Pharma Recent Development
12.14 Astellas Pharma
12.14.1 Astellas Pharma Company Details
12.14.2 Astellas Pharma Business Overview
12.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Introduction
12.14.4 Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
12.14.5 Astellas Pharma Recent Development
12.15 Tide Pharmaceutical
12.15.1 Tide Pharmaceutical Company Details
12.15.2 Tide Pharmaceutical Business Overview
12.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Introduction
12.15.4 Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
12.15.5 Tide Pharmaceutical Recent Development
12.16 Iroko Pharmaceuticals
12.16.1 Iroko Pharmaceuticals Company Details
12.16.2 Iroko Pharmaceuticals Business Overview
12.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Introduction
12.16.4 Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
12.16.5 Iroko Pharmaceuticals Recent Development
12.17 Hengrui Pharmaceutical
12.17.1 Hengrui Pharmaceutical Company Details
12.17.2 Hengrui Pharmaceutical Business Overview
12.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Introduction
12.17.4 Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
12.17.5 Hengrui Pharmaceutical Recent Development
12.18 Abiogen Pharma
12.18.1 Abiogen Pharma Company Details
12.18.2 Abiogen Pharma Business Overview
12.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Introduction
12.18.4 Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
12.18.5 Abiogen Pharma Recent Development
13 Market Dynamics
13.1 Drugs for Osteoarthritis Pain Industry Trends
13.2 Drugs for Osteoarthritis Pain Market Drivers
13.3 Drugs for Osteoarthritis Pain Market Challenges
13.4 Drugs for Osteoarthritis Pain Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author List
15.3 Disclaimer
List of Tables
Table 1. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type (US$ Million): (2018 VS 2022 VS 2029)
Table 2. Major Players of Oral
Table 3. Major Players of Injection
Table 4. Key Players of External
Table 5. Global Drugs for Osteoarthritis Pain Market Size Growth by Application (2018 VS 2022 VS 2029)
Table 6. Global Drugs for Osteoarthritis Pain Market Size (US$ Million) by Region: 2018 VS 2022 VS 2029
Table 7. Global Drugs for Osteoarthritis Pain Revenue (US$ Million) Market Share by Region (2018-2023))
Table 8. Global Drugs for Osteoarthritis Pain Revenue Share by Region (2018-2023)
Table 9. Global Drugs for Osteoarthritis Pain Revenue (US$ Million) Forecast by Region (2024-2029)
Table 10. Global Drugs for Osteoarthritis Pain Revenue Share Forecast by Region (2024-2029)
Table 11. Global Drugs for Osteoarthritis Pain Revenue by Players (2018-2023) & (US$ Million)
Table 12. Global Drugs for Osteoarthritis Pain Revenue Share by Players (2018-2023)
Table 13. Global Drugs for Osteoarthritis Pain Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Osteoarthritis Pain as of 2022)
Table 14. Ranking of Global Top Drugs for Osteoarthritis Pain Companies by Revenue (US$ Million) in 2021
Table 15. Global 5 Largest Players Market Share by Drugs for Osteoarthritis Pain Revenue (CR5 and HHI) & (2018-2023)
Table 16. Key Players Headquarters and Area Served
Table 17. Key Players Drugs for Osteoarthritis Pain Product Solution and Service
Table 18. Date of Enter into Drugs for Osteoarthritis Pain Market
Table 19. Mergers & Acquisitions, Expansion Plans
Table 20. Global Drugs for Osteoarthritis Pain Market Size by Type (2018-2023) & (US$ Million)
Table 21. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2018-2023)
Table 22. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 23. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2024-2029)
Table 24. Global Drugs for Osteoarthritis Pain Market Size by Application (2018-2023) & (US$ Million)
Table 25. Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2018-2023)
Table 26. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 27. Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2024-2029)
Table 28. United States Drugs for Osteoarthritis Pain Revenue by Company (2018-2023) & (US$ Million)
Table 29. United States Drugs for Osteoarthritis Pain Revenue Market Share by Company (2018-2023)
Table 30. United States Drugs for Osteoarthritis Pain Market Size by Type (2018-2023) & ()
Table 31. United States Drugs for Osteoarthritis Pain Market Size by Type (2024-2029) & ()
Table 32. United States Drugs for Osteoarthritis Pain Market Size by Application (2018-2023) & ()
Table 33. United States Drugs for Osteoarthritis Pain Market Size by Application (2024-2029) & ()
Table 34. Europe Drugs for Osteoarthritis Pain Revenue by Company (2018-2023) & (US$ Million)
Table 35. Europe Drugs for Osteoarthritis Pain Revenue Market Share by Company (2018-2023)
Table 36. Europe Drugs for Osteoarthritis Pain Market Size by Type (2018-2023) & (US$ Million)
Table 37. Europe Drugs for Osteoarthritis Pain Market Size by Type (2024-2029) & (US$ Million)
Table 38. Europe Drugs for Osteoarthritis Pain Market Size by Application (2018-2023) & (US$ Million)
Table 39. Europe Drugs for Osteoarthritis Pain Market Size by Application (2024-2029) & (US$ Million)
Table 40. China Drugs for Osteoarthritis Pain Revenue by Company (2018-2023) & (US$ Million)
Table 41. China Drugs for Osteoarthritis Pain Revenue Market Share by Company (2018-2023)
Table 42. China Drugs for Osteoarthritis Pain Market Size by Type (2018-2023) & (US$ Million)
Table 43. China Drugs for Osteoarthritis Pain Market Size by Type (2024-2029) & (US$ Million)
Table 44. China Drugs for Osteoarthritis Pain Market Size by Application (2018-2023) & (US$ Million)
Table 45. China Drugs for Osteoarthritis Pain Market Size by Application (2024-2029) & (US$ Million)
Table 46. Japan Drugs for Osteoarthritis Pain Revenue by Company (2018-2023) & (US$ Million)
Table 47. Japan Drugs for Osteoarthritis Pain Revenue Market Share by Company (2018-2023)
Table 48. Japan Drugs for Osteoarthritis Pain Market Size by Type (2018-2023) & (US$ Million)
Table 49. Japan Drugs for Osteoarthritis Pain Market Size by Type (2024-2029) & (US$ Million)
Table 50. Japan Drugs for Osteoarthritis Pain Market Size by Application (2018-2023) & (US$ Million)
Table 51. Japan Drugs for Osteoarthritis Pain Market Size by Application (2024-2029) & (US$ Million)
Table 52. Southeast Asia Drugs for Osteoarthritis Pain Revenue by Company (2018-2023) & (US$ Million)
Table 53. Southeast Asia Drugs for Osteoarthritis Pain Revenue Market Share by Company (2018-2023)
Table 54. Southeast Asia Drugs for Osteoarthritis Pain Market Size by Type (2018-2023) & (US$ Million)
Table 55. Southeast Asia Drugs for Osteoarthritis Pain Market Size by Type (2024-2029) & (US$ Million)
Table 56. Southeast Asia Drugs for Osteoarthritis Pain Market Size by Application (2018-2023) & (US$ Million)
Table 57. Southeast Asia Drugs for Osteoarthritis Pain Market Size by Application (2024-2029) & (US$ Million)
Table 58. India Drugs for Osteoarthritis Pain Revenue by Company (2018-2023) & (US$ Million)
Table 59. India Drugs for Osteoarthritis Pain Revenue Market Share by Company (2018-2023)
Table 60. India Drugs for Osteoarthritis Pain Market Size by Type (2018-2023) & (US$ Million)
Table 61. India Drugs for Osteoarthritis Pain Market Size by Type (2024-2029) & (US$ Million)
Table 62. India Drugs for Osteoarthritis Pain Market Size by Application (2018-2023) & (US$ Million)
Table 63. India Drugs for Osteoarthritis Pain Market Size by Application (2024-2029) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Description and Business Overview
Table 66. Pfizer Drugs for Osteoarthritis Pain Product
Table 67. Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. Johnson & Johnson Company Details
Table 70. Johnson & Johnson Description and Business Overview
Table 71. Johnson & Johnson Drugs for Osteoarthritis Pain Product
Table 72. Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 73. Johnson & Johnson Recent Development
Table 74. GlaxoSmithKline Company Details
Table 75. GlaxoSmithKline Description and Business Overview
Table 76. GlaxoSmithKline Drugs for Osteoarthritis Pain Product
Table 77. GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 78. GlaxoSmithKline Recent Development
Table 79. Bayer Company Details
Table 80. Bayer Description and Business Overview
Table 81. Bayer Drugs for Osteoarthritis Pain Product
Table 82. Bayer Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 83. Bayer Recent Development
Table 84. Eli Lilly Company Details
Table 85. Eli Lilly Description and Business Overview
Table 86. Eli Lilly Drugs for Osteoarthritis Pain Product
Table 87. Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 88. Eli Lilly Recent Development
Table 89. Novartis Company Details
Table 90. Novartis Description and Business Overview
Table 91. Novartis Drugs for Osteoarthritis Pain Product
Table 92. Novartis Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 93. Novartis Recent Development
Table 94. Sanofi Company Details
Table 95. Sanofi Description and Business Overview
Table 96. Sanofi Drugs for Osteoarthritis Pain Product
Table 97. Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 98. Sanofi Recent Development
Table 99. Horizon Pharma Company Details
Table 100. Horizon Pharma Drugs for Osteoarthritis Pain Product
Table 101. Horizon Pharma Description and Business Overview
Table 102. Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 103. Horizon Pharma Recent Development
Table 104. Abbott Company Details
Table 105. Abbott Drugs for Osteoarthritis Pain Product
Table 106. Abbott Description and Business Overview
Table 107. Abbott Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 108. Abbott Recent Development
Table 109. Mylan Company Details
Table 110. Mylan Description and Business Overview
Table 111. Mylan Drugs for Osteoarthritis Pain Product
Table 112. Mylan Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 113. Mylan Recent Development
Table 114. Daiichi Sankyo Company Details
Table 115. Daiichi Sankyo Description and Business Overview
Table 116. Daiichi Sankyo Drugs for Osteoarthritis Pain Product
Table 117. Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 118. Daiichi Sankyo Recent Development
Table 119. TEVA Company Details
Table 120. TEVA Description and Business Overview
Table 121. TEVA Drugs for Osteoarthritis Pain Product
Table 122. TEVA Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 123. TEVA Recent Development
Table 124. Almatica Pharma Company Details
Table 125. Almatica Pharma Description and Business Overview
Table 126. Almatica Pharma Drugs for Osteoarthritis Pain Product
Table 127. Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 128. Almatica Pharma Recent Development
Table 129. Astellas Pharma Company Details
Table 130. Astellas Pharma Description and Business Overview
Table 131. Astellas Pharma Drugs for Osteoarthritis Pain Product
Table 132. Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 133. Astellas Pharma Recent Development
Table 134. Tide Pharmaceutical Company Details
Table 135. Tide Pharmaceutical Description and Business Overview
Table 136. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product
Table 137. Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 138. Tide Pharmaceutical Recent Development
Table 139. Iroko Pharmaceuticals Company Details
Table 140. Iroko Pharmaceuticals Description and Business Overview
Table 141. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product
Table 142. Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 143. Iroko Pharmaceuticals Recent Development
Table 144. Hengrui Pharmaceutical Company Details
Table 145. Hengrui Pharmaceutical Description and Business Overview
Table 146. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product
Table 147. Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 148. Hengrui Pharmaceutical Recent Development
Table 149. Abiogen Pharma Company Details
Table 150. Abiogen Pharma Description and Business Overview
Table 151. Abiogen Pharma Drugs for Osteoarthritis Pain Product
Table 152. Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 153. Abiogen Pharma Recent Development
Table 154. Drugs for Osteoarthritis Pain Market Trends
Table 155. Drugs for Osteoarthritis Pain Market Drivers
Table 156. Drugs for Osteoarthritis Pain Market Challenges
Table 157. Drugs for Osteoarthritis Pain Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs for Osteoarthritis Pain Market Share by Type: 2022 VS 2029
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. External Features
Figure 5. Global Drugs for Osteoarthritis Pain Market Share by Application: 2022 VS 2029
Figure 6. Medical Care Case Studies
Figure 7. Personal Care Case Studies
Figure 8. Drugs for Osteoarthritis Pain Report Years Considered
Figure 9. Global Drugs for Osteoarthritis Pain Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 10. Global Drugs for Osteoarthritis Pain Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Drugs for Osteoarthritis Pain Revenue Market Share by Region: 2018 VS 2022
Figure 12. United States Drugs for Osteoarthritis Pain Revenue (Million USD) Growth Rate (2018-2029)
Figure 13. Europe Drugs for Osteoarthritis Pain Revenue (Million USD) Growth Rate (2018-2029)
Figure 14. China Drugs for Osteoarthritis Pain Revenue (Million USD) Growth Rate (2018-2029)
Figure 15. Japan Drugs for Osteoarthritis Pain Revenue (Million USD) Growth Rate (2018-2029)
Figure 16. Southeast Asia Drugs for Osteoarthritis Pain Revenue (Million USD) Growth Rate (2018-2029)
Figure 17. India Drugs for Osteoarthritis Pain Revenue (Million USD) Growth Rate (2018-2029)
Figure 18. Global Drugs for Osteoarthritis Pain Market Share by Players in 2022
Figure 19. Global Top Drugs for Osteoarthritis Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Osteoarthritis Pain as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Drugs for Osteoarthritis Pain Revenue in 2022
Figure 21. United States Drugs for Osteoarthritis Pain Market Share by Type (2018-2029)
Figure 22. United States Drugs for Osteoarthritis Pain Market Share by Application (2018-2029)
Figure 23. Europe Drugs for Osteoarthritis Pain Market Share by Type (2018-2029)
Figure 24. Europe Drugs for Osteoarthritis Pain Market Share by Application (2018-2029)
Figure 25. China Drugs for Osteoarthritis Pain Market Share by Type (2018-2029)
Figure 26. China Drugs for Osteoarthritis Pain Market Share by Application (2018-2029)
Figure 27. Japan Drugs for Osteoarthritis Pain Market Share by Type (2018-2029)
Figure 28. Japan Drugs for Osteoarthritis Pain Market Share by Application (2018-2029)
Figure 29. Southeast Asia Drugs for Osteoarthritis Pain Market Share by Type (2018-2029)
Figure 30. Southeast Asia Drugs for Osteoarthritis Pain Market Share by Application (2018-2029)
Figure 31. India Drugs for Osteoarthritis Pain Market Share by Type (2018-2029)
Figure 32. India Drugs for Osteoarthritis Pain Market Share by Application (2018-2029)
Figure 33. Pfizer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2018-2023)
Figure 34. Johnson & Johnson Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2018-2023)
Figure 35. GlaxoSmithKline Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2018-2023)
Figure 36. Bayer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2018-2023)
Figure 37. Eli Lilly Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2018-2023)
Figure 38. Novartis Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2018-2023)
Figure 39. Sanofi Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2018-2023)
Figure 40. Horizon Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2018-2023)
Figure 41. Abbott Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2018-2023)
Figure 42. Mylan Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2018-2023)
Figure 43. Daiichi Sankyo Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2018-2023)
Figure 44. TEVA Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2018-2023)
Figure 45. Almatica Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2018-2023)
Figure 46. Astellas Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2018-2023)
Figure 47. Tide Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2018-2023)
Figure 48. Iroko Pharmaceuticals Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2018-2023)
Figure 49. Hengrui Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2018-2023)
Figure 50. Abiogen Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2018-2023)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs